A retrospective non-interventional cohort study comparing the patient and clinical characteristics of heart failure patients concomitantly prescribed SGLT2 inhibitors and Sacubitril/valsartan
Latest Information Update: 14 Dec 2020
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Glucagon-like peptide-1 receptor agonists; Sodium-glucose transporter 2 inhibitors
- Indications Heart failure
- Focus Therapeutic Use
Most Recent Events
- 17 Nov 2020 Results assessing drug utilization study in heart failure patients concomitantly prescribed sodium-glucose cotransporter-2 Inhibitors and sacubitril/valsartan, presented at the American Heart Association Scientific Sessions 2020
- 30 Oct 2020 New trial record
- 01 Sep 2020 Results (n=2126) presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology